An agency within the U.S. Department of Health and Human Services has awarded Stratatech, a Madison, WI-based maker of human skin tissue, $26 million in new funding.
Stratatech, which is developing cell-based regenerative skin tissue for burn victims and others, said the award will support pediatric studies of StrataGraft, the company’s flagship product.
Stratatech is a subsidiary of Mallinckrodt (NYSE: MNK). The U.K.-based pharmaceuticals giant acquired Stratatech in 2016 for $76 million upfront, plus up to $121 million in potential milestone payments...
...moreShare this article on you social outlets
Our Sponsors
- - Volume: 6 - WEEK: 42 Date: 10/18/2018 8:11:31 AM -